Press Releases
2008
| Aug-11-08 | Cortex Reports Second Quarter Operating Results |
| Aug-6-08 | Cortex’s AMPAKINE Molecule CX717 Has Positive Effects in Opiate–Induced Respiratory Depression in a Phase IIa Clinical Study |
| July-31-08 | Cortex to Provide Top Line Data for CX717 Clinical Trial for the Prevention of Opiate-Induced Respiratory Depression in Humans |
| June-18-08 | CORTEX and Top Alberta Government officials meet to Discuss progress on AMPAKINE Compounds AT The 2008 Bio Conference |
| June-17-08 | Alberta pharmaceutical industry expands international partnerships |
| May-19-08 | Cortex Pharmaceuticals Announces Management Changes |
| May-12-08 | Cortex Annual Shareholder Meeting Notification |
| May-8-08 | Cortex Reports First Quarter Operating Results |
| Mar-31-08 | Cortex Initiates Enrollment in Opiate Induced Respiratory Depression Clinical Trial in Germany Today |
| Mar-17-08 | Cortex Reports Fourth Quarter and Year End Operating Results |
| Mar-10-08 | Cortex Receives Approval from German Regulatory Authority to Proceed With two Clinical Trials for AMPAKINE® CX717 for the Acute Treatment of Respiratory Depression due to Opiate Analgesics |
| Jan-28-08 | Cortex’s CEO to Present at the Roth Capital Partners 20th Annual Orange County Conference |
 |